These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 4101579
21. Hereditary dysfibrinogenemia characterized by slow fibrinopeptide release and competitive inhibition of thrombin. Laugen RH, Bithell TC. Acta Haematol; 1984; 71(3):150-7. PubMed ID: 6424379 [Abstract] [Full Text] [Related]
22. [Hereditary dysfibrinogenaemia. Study of a family (author's transl)]. Voinnesson A, Salaün M. Sem Hop; 1984; 55(33-34):1507-12. PubMed ID: 229560 [Abstract] [Full Text] [Related]
23. [Surgical hemorrhagic syndrome. Elaboration of a practical procedure of investigation and treatment in the absence of a specialized laboratory]. Otteni JC, Boyer C, Girardel JM, Gauthier-Lafaye JP. Anesth Analg (Paris); 1969; 26(1):89-106. PubMed ID: 5793321 [No Abstract] [Full Text] [Related]
25. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance]. Fujimaki M, Ikematsu S, Takeuchi I. Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396 [No Abstract] [Full Text] [Related]
26. [Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen]. Soria J, Soria C. Pathol Biol (Paris); 1974 Nov; 22 suppl():72-9. PubMed ID: 4620099 [No Abstract] [Full Text] [Related]
27. [Parietal thromboplastin time, thromboplastin time fibrinogen, thrombin time and thrombocyte count in healthy and sick newborn infants]. Göbel U, Riech P. Monatsschr Kinderheilkd (1902); 1972 Dec; 120(12):484-8. PubMed ID: 4646962 [No Abstract] [Full Text] [Related]
31. Fibrinogen and the fibrinogenopathies. Morse EE. Ann Clin Lab Sci (1971); 1971 Dec; 1(2):155-61. PubMed ID: 4949447 [No Abstract] [Full Text] [Related]
32. A serum-induced defect in fibrin formation. Deykin D, Silversmith P, Ashford T. J Lab Clin Med; 1970 Nov; 76(5):761-74. PubMed ID: 4249037 [No Abstract] [Full Text] [Related]
33. Fibrinogen Longmont: a dysfibrinogenemia that causes prolonged clot-based test results only when using an optical detection method. Lefkowitz JB, DeBoom T, Weller A, Clarke S, Lavrinets D. Am J Hematol; 2000 Mar; 63(3):149-55. PubMed ID: 10679806 [Abstract] [Full Text] [Related]
34. [Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products]. Stürner KH, Holzhüter H, Ochs HG, Angelkort B, Muchietti F, Wenzel E. Verh Dtsch Ges Inn Med; 1973 Mar; 79():1328-30. PubMed ID: 4790173 [No Abstract] [Full Text] [Related]
35. Consumption coagulopathy: practical principles of diagnosis and management. Nalbandian RM, Henry RL, Mammen EF, Kessler DL, Wolf PL, Camp FR, Conte NF. Mich Med; 1971 Sep; 70(22):793-804. PubMed ID: 5141210 [No Abstract] [Full Text] [Related]
36. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules. Matsuda M, Baba M, Morimoto K, Nakamikawa C. J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002 [Abstract] [Full Text] [Related]
39. Congenital deficiency of fibrin-stabilizing factor. Report of a case and family study. Zahir M. JAMA; 1969 Jan 27; 207(4):751-3. PubMed ID: 5818197 [No Abstract] [Full Text] [Related]